The effect of parenteral emepronium bromide (Cetiprin) on postoperative vesical tenesms after transurethral resection of the prostate. A randomized, placebo-controlled study.
Sixty patients were randomized to treatment with either emepronium bromide (Cetiprin) 25 mg t.i.d. or placebo, both medications administered intramuscularly, after transurethral resection of the prostate. Postoperatively, the number of episodes with vesical tenesms and the need for adjuvant analgesic medication were registered. No significant differences in the number of episodes with vesical tenesms or the need for adjuvant analgesic medication were found between the patients treated with emepronium bromide and those treated with placebo.
Jørgensen
L
L
Willumsen
H
H
Lautorp
J R
JR
Paaschburg
B
B
Kromann
B
B
Andersen
J T
JT
D000368:Aged; D000369:Aged, 80 and over; D002986:Clinical Trials as Topic; D004629:Emepronium / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D010149:Postoperative Pain / Q000188:drug therapy*; D011467:Prostate / Q000601:surgery*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D011897:Random Allocation; D012669:Seminal Vesicles / Q000187:drug effects
D000644:Quaternary Ammonium Compounds; D004629:Emepronium